Management of Antiplatelet Therapy in Patients with Post-Menopausal Bleeding After Carotid Endarterectomy

Assessment of Bleeding Risk vs. Thrombotic Risk

The American College of Cardiology recommends that clopidogrel should be temporarily discontinued while maintaining aspirin therapy during the evaluation of post-menopausal bleeding in patients who recently underwent carotid endarterectomy, to balance the risk of thrombosis against the need to minimize bleeding during evaluation and potential intervention 1, 2
Patients who recently underwent carotid endarterectomy for internal carotid stenosis are at risk for stent thrombosis if antiplatelet therapy is completely discontinued, with the risk of stent thrombosis being highest in the first 6 weeks after stent placement 3
Post-menopausal bleeding requires prompt evaluation with transvaginal ultrasound and endometrial biopsy to rule out endometrial cancer and other serious conditions, and continued antiplatelet therapy increases the risk of bleeding during diagnostic procedures and potential surgical interventions 1, 4

The British Journal of Anaesthesia suggests temporarily discontinuing clopidogrel while maintaining aspirin therapy, which provides continued protection against thrombotic events while reducing overall bleeding risk compared to dual antiplatelet therapy 2, 5
Aspirin maintenance is recommended during the evaluation of post-menopausal bleeding, as it provides some level of antiplatelet protection for the recent carotid endarterectomy, and the European Heart Journal recommends resuming clopidogrel as soon as hemostasis is achieved after diagnostic procedures or interventions 1, 2, 4

The American College of Cardiology and the British Journal of Anaesthesia recommend avoiding complete discontinuation of all antiplatelet therapy if possible, as this significantly increases thrombotic risk, and avoiding prolonged interruption of clopidogrel beyond what is necessary for safe procedural intervention 1, 2, 3
The Circulation journal suggests that if urgent surgery is required and cannot be delayed, continuing aspirin alone carries less bleeding risk than dual therapy but still provides some thrombotic protection 2, 3